Provexis Share Price (PXS)

0.41 0.00 (0.00%) delayed: 10:35PM BST
Bid price 0.37 Open price 0.00
Ask price 0.45 Prev close 0.41
High price 0.00 Spread 17.78%
Low price 0.00 Volume 0

Register now for FREE live Provexis share prices, Provexis stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Provexis Level 2 Data, indepth research tools and investor commentary for Provexis (PXS) and other London Stock Exchange equities.

Provexis Share Price Chart

Advanced Charts >>

Register now for FREE Provexis share price charts

Provexis Share Price Information

Name Provexis Epic PXS
Sector Food Producers ISIN GB00B0923P27
Activites Provexis plc is focused on the development and licensing of its proprietary, scientifically-proven Fruitflow heart-health functional food ingredient. In May 2009, the Company's Fruitflow technology was the first to be substantiated by the European Food Safety Authority (EFSA) under the new Article 13(5) for proprietary and emerging science. In June 2010 it was announced that the Company had entered into a long-term Alliance Agreement with DSM Nutritional Products to commercialise Fruitflow, and in June 2015 the Company confirmed it had agreed significantly enhanced financial terms for its Alliance Agreement with DSM for Fruitflow. The Company's Alliance partner DSM Nutritional Products has developed the market actively for the Company's novel, patented Fruitflow heart-health ingredient in all global markets, with over 50 regional consumer healthcare brands now having been launched by direct customers of DSM, and with a number of further regional brands having been launched through DSM's distributor channels. In June 2016 the Company launched a high quality dietary supplement product containing Fruitflow and Omega-3 which is being sold from a separate, dedicated website on a mail order basis. In April 2017 the Company announced that it had entered into a memorandum of understanding with BY-HEALTH Co., Ltd which is intended to result in a research and collaboration agreement with BY-HEALTH for Fruitflow. The Company also confirmed separately that Provexis and DSM are working with BY-HEALTH to support the planned launch of some Fruitflow based products in the Chinese market. BY-HEALTH is a substantial Chinese listed dietary supplement business which is currently valued in excess of £2bn. Index n/a

Provexis Key Numbers

Latest Share Price (p) 0.41 Net Gearing (%) 76.58
Market Capitalisation (£m) 7.73 Gross Gearing (%) 84.18
Shares in issue (m) 1,885.24 Debt Ratio 0.00
P/E Ratio -20.50 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 6.32
Dividend Yield (%) 0.00 Price to book value 257.67
Dividend cover (x) 0.00 ROCE (%) -1,433.33
Earning per share (p) -0.02 EPS Growth (%) 33.33
52 week high / low 0.70 / 0.32 DPS Growth (%) n/a

Provexis Director Deals

Dec.Date Type Director Pos No. of Shares
15/09/2016 PLAC Dawson Buck CH 10,416,667
07/01/2016 BUY Dawson Buck CH 2,093,567
07/01/2016 BUY Ian Ford FD 2,798,168
20/06/2011 BUY Steven Morrison ED 153,971

More Provexis Director Deals >>

Provexis Company News

More Provexis Company News >>

Register now for FREE Provexis company news

Provexis Share Price Discussions

more than 1 year ago

Provexis Buy at 3.25p - Target 8p (PXS)

LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio. Financial details of the deal were not...

more than 1 year ago

Coca Cola Fruitflow Deal (PXS)

I've heard rumours that the fruitflow deal is being placed with Coca Cola, and in discussion with other large drinks brands, also heard that information on the site today has changed which also points towards this, does anyone have any further information?

more than 1 year ago

times online/second big deal (PXS)

before next months results

Register now for FREE Provexis share price discussions